Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose

Sun, 11th Jun 2023 14:36

(Sharecast News) - Experts believe that the Bank of England will have to jack up its base rate from 4.5% at present to 5.5% by the end of 2023 in order to tame stubbornly high inflation. It was that prospect that had already resulted in lenders and building societies to raise the cost of fixed-rate mortgages or to pull deals altogether, as HSBC did during the preceding week. Higher rates also have implications for the cost of servicing the country's debts, in turn eliminating the Chancellor's already limited headroom to push through tax cuts before the elections. - The Financial Mail on Sunday

Police looking into accusations of financial misconduct by the Scottish National Party have arrested one of its former leaders, Nicola Sturgeon. Sturgeon was one of three individuals arrested as part of Operation Branchform, which is investigating whether £600,000-worth of donations to the independence campaign had been misspent by the party. - Guardian

Melrose boss Simon Peckham made a staunch defence of the takeover outfit in an interview. The executive said predator firms like his were necessary in markets in order to restructure poorly-run corporations that would otherwise just carry on underperforming. But he derided criticism of the firm as slash and burn merchants. Quite the opposite, Melrose had pumped over £1bn into GKN Aerospace. There were about 12 months of hard work left in order to spruce it up, he added. Indeed, Melrose "lover buying businesses and seeing them get better". - The Financial Mail on Sunday

Jeb Smith - also known as "the most feared man in corporate America" - has UK biotech outfit Abcam in its sights. Starboard Value, the hedge fund run by Smith, has taken a roughly 2% stake in the antibody company. Last year, Abcam shelved plans for a London float, instead pursuing a listing on the US Nasdaq Exchange. In parallel, Abcam's founders, Jonathan Milner, is pushing to be reinstalled as executive chairman. On Monday he will send a note to investors arguing that only under his leadership can the company undo its "sustained financial underperformance and value destruction". A spokesman for the company however said that Milner's claim were without merit. - Sunday Times

More News
5 Sep 2014 05:23

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Sep 2014 15:10

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Sep 2014 05:23

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Sep 2014 15:12

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Sep 2014 05:19

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
2 Sep 2014 15:04

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Jul 2014 09:01

Wednesday broker round-up UPDATE

Abcam: Canaccord Genuity ups target price from 375p to 400p and upgrades from hold to buy. ARM Holdings: Deutsche Bank cuts target price from 975p to 950p and maintains a hold recommendation. Credit Suisse lowers target price from 1125p to 1100p and leaves its outperform rating unaltered. Beazley:

Read more
22 Jul 2014 10:45

UK WINNERS & LOSERS: ARM Leads FTSE 100 As Tesco Gives Back Gains

Read more
22 Jul 2014 09:51

Abcam Expects To Slightly Beat Consensus Profit Expectations

Read more
22 Jul 2014 09:37

Tuesday broker round-up UPDATE

Abcam: N+1 Singer places both its target price (prev.: 346p) and its sell recommendation under review. Amiad Water Systems: Oriel lowers target price from 350p to 340p and retains a buy recommendation. Ashmore Group: Espirito Santo ups target price from 371p to 404p, while downgrading to neutral.

Read more
14 Jul 2014 10:11

Monday broker round-up UPDATE

Abcam: Numis cuts target price from 510p to 490p and stays with its add rating. ARM Holdings: Credit Suisse reduces target price from 1200p to 1125p and maintains an outperform rating. AstraZeneca: Jefferies reduces target price from 4850p to 4790p maintaining a hold recommendation. BP: Credit Su

Read more
14 Jul 2014 09:11

UK BROKER RATINGS: HSBC Cuts Easyjet Price Target By 22%

Read more
30 Jun 2014 09:37

Abcam Chairman To Step Down

Read more
30 Jun 2014 07:31

UK MORNING BRIEFING: Shares Rise Amid Rush Of Company Reporting

Read more
27 May 2014 09:31

DIRECTOR DEALINGS: Abcam Executives Awarded Shares

LONDON (Alliance News) - Abcam PLC Monday said Scientific Director Mark Bushfield and Commercial Director Philippe Cotrel were awarded matching shares at no cost under a share incentive plan.

Details are as follows.

Read more

Quickpicks are a member only feature

Login to your account